WMT

125.17

+1.4%↑

COST

1,003.15

+1.1%↑

150.44

-1.8%↓

77.68

+0.21%↑

172.01

+3.27%↑

WMT

125.17

+1.4%↑

COST

1,003.15

+1.1%↑

150.44

-1.8%↓

77.68

+0.21%↑

172.01

+3.27%↑

WMT

125.17

+1.4%↑

COST

1,003.15

+1.1%↑

150.44

-1.8%↓

77.68

+0.21%↑

172.01

+3.27%↑

WMT

125.17

+1.4%↑

COST

1,003.15

+1.1%↑

150.44

-1.8%↓

77.68

+0.21%↑

172.01

+3.27%↑

WMT

125.17

+1.4%↑

COST

1,003.15

+1.1%↑

150.44

-1.8%↓

77.68

+0.21%↑

172.01

+3.27%↑

Home・Akciju saraksts・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Slēgts

SektorsPatēriņa aizsardzības

6.57 -2.95

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

6.43

Max

6.71

Galvenie mērījumi
By Trading Economics
Ienākumi	-7.9M -10M
Pārdošana	-5.3M 31M
Peļņas marža	-32.116
Darbinieki	406

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 16. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-12M 229M
Iepriekšējā atvēršanas cena	9.52
Iepriekšējā slēgšanas cena	6.57

Lifecore Biomedical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. marts 23:12 UTC

Karstas akcijas

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

2026. g. 12. marts 22:15 UTC

Peļņas

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

2026. g. 12. marts 21:42 UTC

Galvenie ziņu notikumi

Stryker Says Cyberattack Disruption Is Continuing

2026. g. 12. marts 21:29 UTC

Galvenie ziņu notikumi

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

2026. g. 12. marts 21:27 UTC

Peļņas

Adobe CEO to Depart as AI Boosts Sales -- Update

2026. g. 12. marts 20:46 UTC

Peļņas

Adobe Posts Higher Sales With CEO Set to Depart

2026. g. 12. marts 20:21 UTC

Galvenie ziņu notikumi

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

2026. g. 12. marts 23:57 UTC

Tirgus saruna

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

2026. g. 12. marts 23:38 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 12. marts 23:38 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

2026. g. 12. marts 22:13 UTC

Peļņas

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

2026. g. 12. marts 22:13 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2026. g. 12. marts 22:13 UTC

Tirgus saruna

Peļņas

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

2026. g. 12. marts 21:16 UTC

Iegādes, apvienošanās, pārņemšana

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

2026. g. 12. marts 21:04 UTC

Peļņas

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q Sales $865M >WPM

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q Net $558.3M >WPM

2026. g. 12. marts 21:02 UTC

Peļņas

Wheaton Precious Metals 4Q EPS $1.23 >WPM

2026. g. 12. marts 20:57 UTC

Tirgus saruna

Galvenie ziņu notikumi

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

2026. g. 12. marts 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 12. marts 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 12. marts 20:15 UTC

Iegādes, apvienošanās, pārņemšana

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

2026. g. 12. marts 20:10 UTC

Peļņas

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

2026. g. 12. marts 20:05 UTC

Peļņas

Adobe 1Q Rev $6.4B >ADBE

2026. g. 12. marts 20:05 UTC

Peļņas

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Salīdzinājums

Cenas izmaiņa

Lifecore Biomedical Inc Prognoze

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Lifecore Biomedical Inc — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.